Nutropin Depot, first long-acting dosage form of recombinant growth hormone, now available.

M2 Presswire, June, 2000

M2 PRESSWIRE-29 June 2000-GENENTECH: Nutropin Depot, first long-acting dosage form of recombinant growth hormone, now available (C)1994-2000 M2 COMMUNICATIONS LTD RDATE:28062000 SOUTH SAN FRANCISCO, Calif. and CAMBRIDGE, Mass. -- Genentech, Inc. (NYSE: DNA) and Alkermes, Inc. (NASDAQ: ALKS) announced today that Nutropin Depot [somatropin (rDNA) for injectable suspension] -- the first long-acting dosage form of recombinant human growth hormone -- is being shipped today to the pediatric endocrine community in the United States.

Nutropin Depot was approved by the U.S. Food and Drug Administration (FDA) on December 23,1999. Nutropin Depot is a long-acting form of Genentech's human growth hormone using Alkermes' ProLease injectable extended-release drug...